Alkermes plc (NASDAQ: ALKS) today reported financial results for the three- and nine-month periods ended Dec. 31, 2013, reflecting the company’s transition to a Dec. 31 fiscal year-end. The company also provided financial expectations for 2014.
“Our financial results were ahead of expectations and driven by the robust performance of our key commercial portfolio, particularly our atypical antipsychotic franchise and VIVITROL®.
Help employers find you! Check out all the jobs and post your resume.
